ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $201,958 | -13.6% | 4,994 | -0.6% | 0.00% | – |
Q4 2022 | $233,763 | -24.3% | 5,025 | -15.9% | 0.00% | – |
Q3 2022 | $309,000 | +50.0% | 5,977 | +116.5% | 0.00% | – |
Q4 2021 | $206,000 | -99.3% | 2,761 | -99.0% | 0.00% | -100.0% |
Q2 2018 | $31,064,000 | +34.3% | 268,025 | -6.2% | 0.02% | +33.3% |
Q1 2018 | $23,124,000 | +24.0% | 285,800 | -10.0% | 0.01% | +33.3% |
Q4 2017 | $18,643,000 | +99.2% | 317,700 | +58.8% | 0.01% | +80.0% |
Q3 2017 | $9,360,000 | +14.7% | 200,000 | -33.1% | 0.01% | +25.0% |
Q4 2013 | $8,157,000 | -32.9% | 299,000 | -43.7% | 0.00% | -33.3% |
Q3 2013 | $12,164,000 | +43.1% | 530,700 | +10.6% | 0.01% | +20.0% |
Q2 2013 | $8,499,000 | – | 479,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |